Cancer Protein IGF2BP3 Drives Metastasis Through Novel Autophagy Mechanism
New research reveals how IGF2BP3 protein promotes triple-negative breast cancer spread by hijacking cellular recycling processes.
389 articles in this topic
New research reveals how IGF2BP3 protein promotes triple-negative breast cancer spread by hijacking cellular recycling processes.
Phase 1/2 umbrella trial matches glioblastoma patients to targeted treatments based on tumor genetics, with temsirolimus showing significant benefit.
Engineered green tea compound nanoparticles activate cellular powerhouses to suppress tumor growth and improve immune response against melanoma.
Scientists develop LP-65, a single molecule targeting two cancer pathways simultaneously, showing enhanced anti-tumor effects in lab studies.
New study reveals how blocking ribosome production makes cancer cells vulnerable to ferroptosis, an iron-dependent cell death pathway.
New research reveals how a cancer-promoting protein reprograms cellular fat production to accelerate tumor progression.
New study reveals how cancer cells reprogram bone immune cells to fuel metastasis, offering potential therapeutic targets.
Researchers used advanced genetic analysis to find LGALS9 and SELL genes causally linked to aggressive brain tumors, revealing new treatment targets.
Nationwide French study reveals benzodiazepine use significantly worsens survival outcomes in lung cancer patients receiving pembrolizumab immunotherapy.
New fusion model combines hypoxia and immune markers to predict hepatocellular carcinoma treatment success non-invasively.
Trastuzumab deruxtecan demonstrates potential benefits in treating residual HER2-positive early breast cancer patients.
Engineered immune cell vesicles first induce cancer cell senescence with chemo, then eliminate them with targeted senolytic drugs.